Variable |
|
BF |
|
|
|
|
|
Number |
BF |
% |
p |
Race |
Yellow |
17 |
1 |
5,9 |
<0.001 |
|
White |
181 |
49 |
27,1 |
|
|
Black |
18 |
10 |
55,6 |
|
|
Brown |
13 |
5 |
38,5 |
|
|
|
|
|
|
|
CS |
< 2b |
160 |
35 |
21,9 |
0.004 |
|
≥ 2b |
69 |
30 |
43,5 |
|
|
|
|
|
|
|
Neoadj HT |
Yes |
107 |
25 |
23,4 |
0.152 |
|
No |
122 |
40 |
32,8 |
|
|
|
|
|
|
|
Adj HT |
Yes |
173 |
50 |
28,9 |
|
|
No |
56 |
15 |
26,8 |
|
|
|
|
|
|
|
Risk Group |
Intermediate |
122 |
25 |
20,5 |
0.055 |
|
High |
107 |
40 |
37,4 |
|
|
|
|
|
|
|
HDR Dose (Gy) |
< 20 |
85 |
45 |
52,9 |
<0.001 |
|
20-24 |
144 |
20 |
13,9 |
|
|
|
|
|
|
|
iPSA |
<10 |
56 |
20 |
35,7 |
0.225 |
|
10-20 |
105 |
25 |
23,8 |
|
|
>20 |
68 |
20 |
29,4 |
|
|
|
|
|
|
|
GS |
<7 |
146 |
36 |
24,7 |
0.001 |
|
7 |
56 |
18 |
32,1 |
|
|
>7 |
27 |
11 |
40,7 |
|
GS – reference 7 |
≤ 7 |
202 |
54 |
26,7 |
0.009 |
|
>7 |
27 |
11 |
40,7 |
|
|
|
|
|
|
|
EBRT |
<50 |
125 |
39 |
31.2 |
|
|
≥ 50 |
104
|
26 |
25.0 |
0.060 |
|
|
|
|
|
|
Age |
≥ 65 |
75 |
25 |
33.3 |
0.094 |
|
>65 |
154 |
40 |
26.0 |
|
iPSA: Initial PSA Value; GS: Geason Score; IR: Intermediate Risk; HR: High Risk;
neoadj HT: Neoadjuvant Androgen Deprivation; adj HT: Neoadjuvant Androgen
Deprivation; EBRT: External Beam Radiotherapy; HDR-BT: High Dose Rate
Brachytherapy |